Macrogenics (MGNX) Gross Profit (2020 - 2025)

Macrogenics (MGNX) has 6 years of Gross Profit data on file, last reported at $41.2 million in Q4 2025.

• On a quarterly basis, Gross Profit rose 3.67% year-over-year to $41.2 million in Q4 2025; TTM through Dec 2025 was $149.5 million, a 11.94% decrease from a year earlier, with the FY2025 full-year figure at $149.5 million, changed 0.26% from the prior year.
• Gross Profit for Q4 2025 stood at $41.2 million, down from $72.8 million in the prior quarter.
• Over the last five years, Gross Profit for MGNX reached as high as $110.5 million in Q3 2024 and fell as low as $8.8 million in Q1 2024.
• Historically, Gross Profit has averaged $30.0 million across 5 years, with a median of $19.6 million in 2021.
• Across the five-year window, Gross Profit tumbled 85.53% in 2023 and jumped 971.96% in 2024, its largest moves.
• Year by year, Gross Profit stood at $13.2 million in 2021, then surged by 452.9% to $73.0 million in 2022, then tumbled by 85.53% to $10.6 million in 2023, then soared by 276.69% to $39.8 million in 2024, then rose by 3.67% to $41.2 million in 2025.
• Per Business Quant data, the three most recent Gross Profit figures were $41.2 million in Q4 2025, $72.8 million in Q3 2025, and $22.2 million in Q2 2025.